Telix Completes Acquisition of Atlab for Prostate Cancer Program

Go back to Telix Completes Acquisition of Atlab for Prostate Cancer Program
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.96 -0.14 (1.39%)
Previous Close $10.10    52 Week High $2.18 
Open $10.04    52 Week Low $0.30 
Day High $10.04    P/E N/A 
Day Low $9.94    EPS $-3.32 
Volume 18,171